An earlier study showed that COVID-19 patients have substantially higher anti-glycan antibodies (i.e., IgG and IgM) against self-glycans (e.g., N-glycans, LacNAc-containing glycans, gangliosides, sialyl Lewis X, and blood group H), compared to healthy controls (30). Here, FUT4 is linked to COVID-19.